China-based Yiling Pharmaceutical recently issued a notice that it had received a certificate of drug registration granted by the Pharmaceutical and Herbal Medicine Registration and Control Administration of Kuwait that certified its drug - Lianhua Qingwen capsules - as a herbal medicine to be registered in Kuwait.
(Yicai Global) Sept. 4 -- The Kuwait government has rubber stamped a traditional Chinese herbal medicine for the treatment of Covid-19 in the first international endorsement of its kind, the drug’s producer Shijiazhuang Yiling Pharmaceutical said today.
The Philippines’ Food and Drug Administration (FDA) has approved the traditional Chinese medicine (TCM) capsule Lianhua Qingwen widely used in China as part of its standard coronavirus treatments.
MANILA, Aug. 12 (Xinhua) -- The Chinese Embassy in the Philippines on Wednesday welcomed the approval of the popular traditional Chinese medicine Lianhua Qingwen, a treatment for the novel coronavirus disease (COVID-19).
The Chinese Embassy in the Philippines is glad to learn that the Philippine Food and Drug Administration (FDA) has approved Chinese drug Lian Hua Qing Wen produced by one of China's renowned Traditional Chinese Medicine (TCM) manufacturers, Shijiazhuang Yiling Pharmaceutical Co. Ltd., making the drug formally registered as TCM in the Philippines. This marks an important progress in the entry of TCM products into the Philippine market, which we welcome.